{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T09:34:08Z","timestamp":1702632848946},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00393-005-0664-1","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T21:54:01Z","timestamp":1129931641000},"page":"499-502","source":"Crossref","is-referenced-by-count":10,"title":["PM-Scl-Antik\u00f6rper positive systemische Sklerodermie assoziiert mit Einschlussk\u00f6rper-Myositis","PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis"],"prefix":"10.1007","volume":"64","author":[{"given":"S.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Genth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Hunzelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"664_CR1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.45.7.1302","volume":"45","author":"Barohn","year":"1995","unstructured":"Barohn RJ, Amato AA, Sahenk Z, Kissel JT, Mendell JR (1995) Inclusion body myositis: Explanation for poor response to immunosuppressive therapy. Neurology 45:1302\u20131304","journal-title":"Neurology"},{"key":"664_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11940-000-0019-9","volume":"2","author":"Barohn","year":"2000","unstructured":"Barohn RJ, Amato AA (2000) Inclusion body myosits. Curr Treat Options Neurol 2:7\u201312","journal-title":"Curr Treat Options Neurol"},{"key":"664_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"Brouwer","year":"2001","unstructured":"Brouwer R, Hengstmann GJD, Vree Egbert W et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116\u2013123","journal-title":"Ann Rheum Dis"},{"key":"664_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/art.1780300406","volume":"30","author":"Calabrese","year":"1987","unstructured":"Calabrese LH, Mitsumoto H, Chou SM (1987) Inclusion body myositis presenting as treatment-resistant polymyositis. Arthritis Rheum 30:397\u2013403","journal-title":"Arthritis Rheum"},{"key":"664_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00002281-199911000-00002","volume":"11","author":"Cherin","year":"1999","unstructured":"Cherin P (1999) Treatment of inclusion body myositis. Curr Opin Rheumatol 11:436\u2013461","journal-title":"Curr Opin Rheumatol"},{"key":"664_CR6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","volume":"48","author":"Dalakas","year":"1997","unstructured":"Dalakas MC, Sonies B, Dambrosia J, Sekul E (1997) Treatment of inclusion body myositis with IVIg. Neurology 48:712\u2013716","journal-title":"Neurology"},{"key":"664_CR7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"21","author":"Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 21:1487\u20131498","journal-title":"N Engl J Med"},{"key":"664_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archneur.1982.00510240022006","volume":"39","author":"Danon","year":"1982","unstructured":"Danon MJ, Reyes MG, Perurena OH, Masdeu JC, Manaligod JR (1982) Inclusion body myositis a corticosteroid-resistant idiopathic inflammatory myopathy. Arch Neurol 39:760\u2013764","journal-title":"Arch Neurol"},{"key":"664_CR9","first-page":"39","volume":"54","author":"Genth","year":"1995","unstructured":"Genth E, Mierau R (1995) Diagnostische Bedeutung Sklerodermie- und Myositis-assoziierter Autoantik\u00f6rper. Z Rheumatol 54:39\u201349","journal-title":"Z Rheumatol"},{"key":"664_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s001080050537","volume":"41","author":"Genth","year":"2000","unstructured":"Genth E (2000) Entz\u00fcndliche Muskelkrankheiten aus internistischer Sicht. Internist 41:445\u2013454","journal-title":"Internist"},{"key":"664_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410440325","volume":"44","author":"Hengstmann","year":"1998","unstructured":"Hengstmann GJD, van Engelen BGM, Badrising UA, van den Hoogen FHJ, van Venrooij WJ (1998) Presence of the anti-Jo-1 autoantibody excludesinclusion body myositis. Ann Neurol 44:423","journal-title":"Ann Neurol"},{"key":"664_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4615-4857-7_12","volume":"45","author":"Jablonska","year":"1999","unstructured":"Jablonska S, Blaszczyk M (1999) Scleroderma overlap syndromes. Rheuma Derm 45:85\u201392","journal-title":"Rheuma Derm"},{"key":"664_CR13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","volume":"21","author":"Koffman","year":"1998","unstructured":"Koffman BM, Rugiero M, Dalakas MC (1998) Immune mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 21:115\u2013117","journal-title":"Muscle Nerve"},{"key":"664_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00005792-199307000-00002","volume":"72","author":"Leff","year":"1993","unstructured":"Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH (1993) The treatment of inclusion body myositis: A retrospective and a randomized, propective trial of immunosuppressive therapy. Medicine 72:225\u2013235","journal-title":"Medicine"},{"key":"664_CR15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/112.3.727","volume":"112","author":"Lotz","year":"1989","unstructured":"Lotz BP, Engel AG, Nishino H, Stevens JC (1989) Inclusion body myositis. Observations in 40 patients. Brain 112:727\u2013747","journal-title":"Brain"},{"key":"664_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","volume":"71","author":"Marguerie","year":"1992","unstructured":"Marguerie C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, So AK, Walport MJ (1992) The clinical and immunogenetic features of patients with autoantibodies to the nuclear antigen PM-Scl. Medicine (Baltimore) 71:327\u2013336","journal-title":"Medicine"},{"key":"664_CR17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archneur.1991.00530240033013","volume":"48","author":"Mendell","year":"1991","unstructured":"Mendell JR, Sahenk Z, Gales T, Paul Z (1991) Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments. Arch Neurol 48:1229\u20131234","journal-title":"Arch Neurol"},{"key":"664_CR18","unstructured":"Mikols J, Engel AG (1994) Inclusion body myositis. In: Engel AG, Franzini-Armstrong CF, editors: Myology, 2nd edition, Mc Graw-Hill Inc, pp 1384\u20131398"},{"key":"664_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00002281-199611000-00005","volume":"8","author":"Mimori","year":"1996","unstructured":"Mimori T (1996) Structures targeted by the immune system in myositis. Curr Opin Rheumatol 8:521\u2013527","journal-title":"Curr Opin Rheumatol"},{"key":"664_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(01)00478-6","volume":"185","author":"Mowzoon","year":"2001","unstructured":"Mowzoon N, Sussman A, Bradley WG (2001) Mycophenolate (Cellcept) treatment of myastenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis. J Neurol Sci 185:119\u2013122","journal-title":"J Neurol Sci"},{"key":"664_CR21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","volume":"35","author":"Oddis","year":"1992","unstructured":"Oddis CV, Okano Y, Rudert WA, Trucco M, Dusaquesnoy RJ, Medsger Ta Jr (1992) Serum autoantibody to the nuclear autoantigen PM-Scl: clinical and immunogenic associations. Arthritis Rheum 35:1211\u20131217","journal-title":"Arthritis Rheum"},{"key":"664_CR22","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.137.12.3802","volume":"137","author":"Reimer","year":"1986","unstructured":"Reimer G, Scheer U, Peters JM, Tan EM (1986) Immunolocalisation and partial characterization of a nuclear autoantigen (PM-Scl) associated with polymyositis\/scleroderma overlap syndrome. J Immunol 137:3802\u20133808","journal-title":"J Immunol"},{"key":"664_CR23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/anr.1780320611","volume":"32","author":"Richter Cohen","year":"1989","unstructured":"Richter Cohen M, Sulaiman AR, Garanics JC, Wortman RL (1989) Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis Rheum 32:734\u2013740","journal-title":"Arthritis Rheum"},{"key":"664_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000117215","volume":"36","author":"Schlesinger","year":"1996","unstructured":"Schlesinger I, Soffer D, Lossos A, Meiner Z, Argov Z (1996) Inclusion body myositis: atypical clinical presentation. Eur Neurol 36:89\u201393","journal-title":"Eur Neurol"},{"key":"664_CR25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-2008-1041132","volume":"13","author":"Sekul","year":"1993","unstructured":"Sekul EA, Dalakas MC (1993) Inclusion body myositis: New concepts. Sem Neurol 13:256\u2013263","journal-title":"Sem Neurol"},{"key":"664_CR26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keg253","volume":"42","author":"Selva-O\u2019Callaghan","year":"2003","unstructured":"Selva-O\u2019Callaghan A, Mijares-Boeckh-Behrens T, Labrador-Horillos M, Soalns-Laque R, Ma Grau-Junyent J, Vilardell-Tarres M (2003) Anti-PMScl antibodies in a patient with inclusion body myositis. Rheumatology (Oxford) 42:1016\u20131018","journal-title":"Rheumatology"},{"key":"664_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00125480-199805000-00003","volume":"5","author":"Vogel","year":"1998","unstructured":"Vogel H (1998) Inclusion body myositis\u2014a review. Adv Anat Pathol 5:164\u2013169","journal-title":"Adv Anat Pathol"},{"key":"664_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11940-004-0024-5","volume":"6","author":"Grogan","year":"2004","unstructured":"Grogan PM, Katz JS (2004) Inflammatory myopathies. Curr Treat Options Neurol 6:155\u2013161","journal-title":"Curr Treat Options Neurol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-005-0664-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-005-0664-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-005-0664-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:32:20Z","timestamp":1683264740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-005-0664-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s00393-005-0664-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}